首页> 美国卫生研究院文献>BMJ Open Access >Percutaneous coronary intervention in the UK: recommendations for good practice 2015
【2h】

Percutaneous coronary intervention in the UK: recommendations for good practice 2015

机译:英国的经皮冠状动脉介入治疗:2015年优良作法建议

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Over the last 35 years, there has been dramatic progress in the technology and applicability of percutaneous techniques to treat obstructive coronary heart disease. Percutaneous coronary intervention (PCI) has a considerable evidence base and it is firmly established as the most common procedure used in the invasive treatment of patients with coronary heart disease in the UK. This set of guidelines aims to address specifically issues relating to PCI and not the growing subspecialty of structural heart disease intervention. It is not intended to provide a review of the entire evidence base for coronary intervention. The evidence base relating to PCI is extensively reviewed in international guidelines and the British Cardiovascular Intervention society endorses these guidelines and their updates. The guidelines presented here focus on issues pertinent to practice within the UK and set out a recommended template to ensure optimal delivery of patient care.
机译:在过去的35年中,经皮治疗阻塞性冠心病的技术和适用性取得了巨大进步。经皮冠状动脉介入治疗(PCI)具有相当大的证据基础,并且已被牢固确立为英国侵入性治疗冠心病患者最常用的方法。这套指南旨在专门解决与PCI相关的问题,而不是结构性心脏病干预的日益专业化。它无意对冠状动脉介入治疗的整个证据基础进行回顾。有关PCI的证据基础已在国际指南中进行了广泛审查,英国心血管介入学会也认可这些指南及其更新。此处介绍的指南重点关注与英国境内实践相关的问题,并提出了建议的模板以确保患者护理的最佳交付。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号